Surmodics Inc. (SRDX)
30.71
1.25 (4.24%)
Apr 28, 2025, 1:14 PM - Market open
4.24% (1D)
| Bid | 30.55 |
| Market Cap | 439.03M |
| Revenue (ttm) | 125.45M |
| Net Income (ttm) | -14.41M |
| EPS (ttm) | -1.02 |
| PE Ratio (ttm) | -30.11 |
| Forward PE | 128.52 |
| Analyst | Hold |
| Ask | 30.87 |
| Volume | 44,008 |
| Avg. Volume (20D) | 193,742 |
| Open | 29.39 |
| Previous Close | 29.46 |
| Day's Range | 29.39 - 30.97 |
| 52-Week Range | 25.17 - 42.44 |
| Beta | 1.30 |
About SRDX
Surmodics, Inc., together with its subsidiaries, provides surface modification technologies for intravascular medical devices, and chemical components for in vitro diagnostic immunoassay tests and microarrays in the United States and internationally. It operates in two segments, Medical Device and In Vitro Diagnostics (IVD). The Medical Device segment engages in the provision of surface modification coating technologies to enhance access, deliver...
Industry Medical - Devices
Sector Healthcare
IPO Date Mar 4, 1998
Employees 389
Stock Exchange NASDAQ
Ticker Symbol SRDX
Website https://www.surmodics.com
Analyst Forecast
According to 4 analyst ratings, the average rating for SRDX stock is "Hold." The 12-month stock price forecast is $43, which is an increase of 40.02% from the latest price.
Stock ForecastsNext Earnings Release
Surmodics Inc. is scheduled to release its earnings on May 9, 2025,
before market opens.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
11 months ago
+19.94%
Surmodics shares are trading higher after the comp...
Unlock content with
Pro Subscription
